Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines

Authors: Limcangco M.R.M.T.1; Armour C.L.2; Salole E.G.2; Taylor S.J.2

Source: PharmacoEconomics, Volume 19, Number 4, 1 April 2001 , pp. 391-400(10)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: Haemophilus influenzae type b (Hib) meningitis is associated with high mortality and serious sequelae in children under 5 years of age. Vaccines which can prevent this infection are available.

Objective: To evaluate the costs and benefits of a 3-dose immunisation schedule in Manila, Philippines.

Perspective: Government and societal perspectives.

Design and participants: A cost-benefit analysis based on a birth cohort of 100 000 children. The state of health of the cohort with and without a Hib immunisation programme was modelled over a 5-year period. A survey of medical records of patients with Hib in Manila provided data on the extent and cost of sequelae following infection.

Intervention: A 3-dose Hib vaccination programme given at ages 2, 3 and 4 months.

Results: The model predicted that vaccinating children against Hib meningitis would prevent 553 cases per year in a birth cohort of 100 000, at a cost of 56 200 Philippine pesos (PHP) [$US1605; 1998 exchange rate] per case (base case assumptions of 90% vaccine efficacy rate, 95 per 100 000 Hib incidence rate, 85% vaccination coverage). Results from the cost-benefit analyses indicated that the saving to the government would be around PHP39 million ($US1.11 million), and the saving to society would be PHP255 million ($US7.28 million).

Conclusion: There would be a positive economic benefit for the Philippine government and for the Filipino society if a Hib vaccination programme was introduced in Manila.

Keywords: Children; Cost benefit; Haemophilus meningitis, prevention; Hib vaccine, therapeutic use; Pharmacoeconomics; Vaccines, therapeutic use

Document Type: Original article

Affiliations: 1: Department of Pharmacy, College of Pharmacy, University of the Philippines - Manila, Manila, Philippines 2: School of Pharmacy, University of Sydney, New South Wales, Australia

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$62.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A